Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Moshe Sade-Feldman(Broad Institute), Keren Yizhak(Broad Institute), Stacey L. Bjorgaard(Broad Institute), John P. Ray(Broad Institute), Carl G. de Boer(Broad Institute), Russell W. Jenkins(Harvard University), David Lieb(Broad Institute), Jonathan Chen(Broad Institute), Dennie T. Frederick(Harvard University), Michal Barzily-Rokni(Harvard University), Samuel S. Freeman(Broad Institute), Alexandre Reuben(The University of Texas MD Anderson Cancer Center), Paul Hoover(Broad Institute), Alexandra–Chloé Villani(Broad Institute), Elena V. Ivanova(Massachusetts General Hospital), Andrew Portell(Massachusetts General Hospital), Patrick H. Lizotte(Massachusetts General Hospital), Amir Reza Aref(Massachusetts General Hospital), Jean-Pierre Eliane(Massachusetts General Hospital), Marc R. Hammond(Harvard University), Hans Vitzthum(Harvard University), Shauna Blackmon(Harvard University), Bo Li(Broad Institute), Vancheswaran Gopalakrishnan(The University of Texas MD Anderson Cancer Center), Sangeetha M. Reddy(The University of Texas MD Anderson Cancer Center), Zachary A. Cooper(The University of Texas MD Anderson Cancer Center), Cloud P. Paweletz(Massachusetts General Hospital), David A. Barbie(Massachusetts General Hospital), Anat Stemmer‐Rachamimov(Massachusetts General Hospital), Keith T. Flaherty(Harvard University), Jennifer A. Wargo(The University of Texas MD Anderson Cancer Center), Genevieve M. Boland(Harvard University), Ryan J. Sullivan(Harvard University), Gad Getz(Broad Institute), Nir Hacohen(Broad Institute)
Cited by 2,022Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis